Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;98(10):1581-5.
doi: 10.3324/haematol.2013.084830. Epub 2013 Jun 28.

Schnitzler syndrome: an under-diagnosed clinical entity

Affiliations

Schnitzler syndrome: an under-diagnosed clinical entity

Tania Jain et al. Haematologica. 2013 Oct.

Abstract

Schnitzler syndrome is considered to be a rare disorder characterized by a monoclonal IgM protein and chronic urticaria that is associated with considerable morbidity. We hypothesized that the syndrome may be under-recognized and patients may be deprived of highly effective therapy in the form of anakinra. We performed a retrospective search of the dysproteinemia database at Mayo Clinic as well as the medical records of all patients with chronic urticaria to determine the true incidence of the disease. We compared patients with the diagnosis of Schnitzler syndrome and those who met the criteria but in whom the syndrome was not recognized. Comparisons between groups were performed and survival curves determined. We identified 16 patients with diagnosed Schnitzler syndrome and an additional 46 patients who met diagnostic criteria. The monoclonal protein was IgMκ in 94% of patients. Therapy with anakinra in 4 patients led to rapid and complete resolution of symptoms. The median overall survival for this syndrome is over 12.8 years. Progression to lymphoma was only observed in 8% of patients; this is lower than previous reports. Schnitzler syndrome may be present in up to 1.5% of patients with a monoclonal IgM in their serum and likely under-recognized as a clinical syndrome.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overall survival for the combined cohort (n=62). For this analysis the 16 patients with Schnitzler syndrome were combined with 46 other patients who met diagnostic criteria.
Figure 2.
Figure 2.
Prognostic impact of hemoglobin at the time of diagnosis. Survival of the 62 patients was analyzed as a function of hemoglobin at the time of diagnosis. Hemoglobin below 12.2 g/dL was the only P adverse prognostic factor ( =0.024, log rank test).

Similar articles

Cited by

  • Beyond Urticaria: Schnitzler Syndrome.
    Ruiz-Villaverde R, Bueno-Rodriguez A, Sánchez-Cano D. Ruiz-Villaverde R, et al. Balkan Med J. 2017 Sep 29;34(5):478-479. doi: 10.4274/balkanmedj.2017.0259. Epub 2017 May 29. Balkan Med J. 2017. PMID: 28552842 Free PMC article. No abstract available.
  • Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.
    Ujiie H, Rosmarin D, Schön MP, Ständer S, Boch K, Metz M, Maurer M, Thaci D, Schmidt E, Cole C, Amber KT, Didona D, Hertl M, Recke A, Graßhoff H, Hackel A, Schumann A, Riemekasten G, Bieber K, Sprow G, Dan J, Zillikens D, Sezin T, Christiano AM, Wolk K, Sabat R, Kridin K, Werth VP, Ludwig RJ. Ujiie H, et al. Front Med (Lausanne). 2022 Jun 9;9:875492. doi: 10.3389/fmed.2022.875492. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35755063 Free PMC article. Review.
  • Treatment of Patients with Monoclonal Gammopathy of Clinical Significance.
    Moreno DF, Rosiñol L, Cibeira MT, Bladé J, Fernández de Larrea C. Moreno DF, et al. Cancers (Basel). 2021 Oct 13;13(20):5131. doi: 10.3390/cancers13205131. Cancers (Basel). 2021. PMID: 34680279 Free PMC article. Review.
  • Radiotherapy for a breast cancer patient with Schnitzler syndrome: Report of acute toxicity and early follow-up.
    Hanna SA, Calich ALG, Katz A, Calich I, Duarte GG, Bevilacqua JLB. Hanna SA, et al. Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):463-469. doi: 10.1016/j.rpor.2017.08.006. Epub 2017 Sep 8. Rep Pract Oncol Radiother. 2017. PMID: 28932175 Free PMC article.
  • [Diagnosis and treatment of Schnitzler syndrome].
    Zhang XR, Jia SX, Fang MY. Zhang XR, et al. Zhonghua Xue Ye Xue Za Zhi. 2018 Dec 14;39(12):1052-1056. doi: 10.3760/cma.j.issn.0253-2727.2018.12.018. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 30612413 Free PMC article. Chinese. No abstract available.

References

    1. Schnitzler L. Lésions urticariennes chroniques permanentes (érythème pétaloïde?). Cas cliniques. Journee Dermatologique d’Angers. 1972(46).
    1. Schnitzler L, Schubert B, Boasson M, Gardais J, Tourmen A. Urticaire chronique, lésions osseuses, macroglobulinémie IgM: maladie de Waldenström. Bull Soc Fr Dermatol Syphiligr. 1974;81:363
    1. Lipsker D, Veran Y, Grunenberger F, Cribier B, Heid E, Grosshans E. The Schnitzler syndrome. Four new cases and review of the literature. Medicine (Baltimore). 2001;80(1): 37–44 - PubMed
    1. de Koning HD, Bodar EJ, van der Meer JW, Simon A. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum. 2007;37 (3):137–48 - PubMed
    1. Lipsker D. The Schnitzler syndrome. Orphanet J Rare Dis. 2010;5(38):20. - PMC - PubMed

Substances

LinkOut - more resources